Yuzhong Chen
Jiangsu Key Laboratory Of Innovative Cancer Diagnosis & Therapeutics
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
AI-driven dual-task prediction model for co-stratifying efficacy and toxicity in NSCLC immunotherapy.
Journal: PLOS digital health
Published: November 10, 2025
The recruitment of CD8+ T cells through YBX1 stabilization abrogates tumor intrinsic oncogenic role of MIR155HG in lung adenocarcinoma.
Journal: Cell death discovery
Published: May 13, 2024
Excessive MYC Orchestrates Macrophages induced Chromatin Remodeling to Sustain Micropapillary-Patterned Malignancy in Lung Adenocarcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 12, 2024
Deep learning-based detection and semi-quantitative model for spread through air spaces (STAS) in lung adenocarcinoma.
Journal: NPJ precision oncology
Published: December 16, 2023
Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy.
Journal: Therapeutic advances in medical oncology
Published: June 12, 2023
N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma.
Journal: Thoracic cancer
Published: May 29, 2023
The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma.
Journal: Cell death & disease
Published: January 21, 2023
Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway.
Journal: Journal of hematology & oncology
Published: April 05, 2022
Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study.
Journal: Translational lung cancer research
Published: February 18, 2022
Last Updated: 09/26/2026